TL;DR Benefit-risk assessment in pharmacovigilance is the process of evaluating whether a drug’s therapeutic benefits outweigh its potential risks. Pharmacovigilance teams analyze safety signals, review
TL;DR Understanding post-approval changes in pharma is essential for maintaining product compliance after initial approval. Regulatory affairs teams manage updates through structured processes that ensure
TL;DRCAPA in pharmaceutical quality assurance is how quality teams prevent repeat issues. When deviations occur, QA investigates what happened, identifies the root cause, documents a
TL;DR Career opportunities after pharmaceutical training are evolving rapidly. From personalized medicine to data-driven drug development and growing pharmacovigilance needs, today’s pharmaceutical training opens doors
Periodic safety reports play a central role in how drug safety teams evaluate and manage risk throughout a product’s lifecycle. From early post-marketing stages to
Signal detection is one of the most essential functions within drug safety and pharmacovigilance. Whether identifying a rare adverse event or recognizing an unexpected safety
Stay up to date on the latest Programs and Events…
Please fill in your details and we’ll contact you shortly.
Please fill the form below
